학술논문
OUTCOMES IN HIGHLY SENSITIZED PATIENTS TREATED WITH INTRAVENOUS IMMUNE GLOBULIN (IVIG) PRIOR TO LIVING DONOR KIDNEY TRANSPLANTATION.
Document Type
Article
Author
Source
Transplantation; 2006 Supplement, Vol. 82, p783-783, 1p
Subject
Language
ISSN
00411337